ClinicalTrials.Veeva

Menu

Footwear Difference in Sports Use in Runners With Functional Equinus

U

Universidad Católica de Ávila

Status

Enrolling

Conditions

Sport Injury

Treatments

Other: 250 mg Nimbus shoe

Study type

Observational

Funder types

Other

Identifiers

NCT06930287
13/12/2024

Details and patient eligibility

About

Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. This is a Novablast shoe with a mixed profile for training and competition with 8mm drp and higher midfoot compression range with less lateral containment.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with functional equine
  • regular runners

Exclusion criteria

  • patients with severe heterometry (more than 1 cm).
  • Recent lower limb interventions

Trial design

20 participants in 1 patient group

300 mg Nimbus shoe
Treatment:
Other: 250 mg Nimbus shoe

Trial contacts and locations

1

Loading...

Central trial contact

Jorge Velázquez SAORNIL, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems